Viracta Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Viracta Therapeutics Inc
CIK #0001061027, 0001416377
EDGAR Form CIK 2011 - 2026
10-K [0001061027]
10-Q [0001061027]
3 [0001061027]
4 [0001061027]
8-K [0001061027]
SC 13D [0001061027]
SC 13G [0001061027]
D [0001416377]
SC 13D [0001416377]
SC 13G [0001416377]
Form 13D/13G Filer Form 13D/13G Subject Filed
Forward Ventures V LP Viracta Therapeutics Inc [2025-02-14]
Forward Ventures V LP Viracta Therapeutics Inc [2024-02-13]
BlackRock Inc Viracta Therapeutics Inc [2022-07-08]
Aisling Capital IV LP Viracta Therapeutics Inc [2022-02-14]
BlackRock Inc Viracta Therapeutics Inc [2022-02-04]
Forward Ventures V LP Viracta Therapeutics Inc [2021-03-08]
LVP Life Science Ventures III LP Viracta Therapeutics Inc [2021-03-04]
Schindel Yair Chaim Sunesis Pharmaceuticals Inc [2021-03-02]
Schindel Yair Chaim Viracta Therapeutics Inc [2021-03-01]
Lytton Laurence W Sunesis Pharmaceuticals Inc [2021-01-04]
View All
Form 3/4/5 Subject 2011 - 2026
Royston IVOR
Sunesis Pharmaceuticals Inc
Pomerantz Roger
Rubino Stephen
Darcy Thomas E
Simon Barry J
Barlow Jane F
Borellini Flavia
Chung Jane
Murphy Samuel Lafayette
Faerm Michael E
Burcar Melody
Chevallard Daniel R
Rothera Mark
Cohen Darrel P
Rojkjaer Lisa
Onetto Nicole
Huang Michael
Roshwalb Gur
aMoon Growth Fund Limited Partnership
Schindel Yair Chaim
Hyare Parvinder Singh
Wolff Henry Ward
Ketchum Steven B
Stump David C
Carchedi Steve
Young James W
Misfeldt Dayton
Pearce Homer L
Gullotta Tina
Quinn William P
Fox Judith A
Elms Steve
Aisling Capital Partners IV LP
Schiff Andrew N
Aisling Capital Partners IV LLC
Aisling Capital IV LP
Oncology Impact Fund Cayman Management LP
MPM Oncology Impact Management GP LLC
MPM BioImpact LLC
UBS Oncology Impact Fund LP
Swisher Daniel N JR
Parker Geoffrey M
Bjerkholt Eric
Fust Matthew
Bay City Capital Fund V Co-Investment Fund LP
Bay City Capital Fund V LP
Bay City Capital Management V LLC
Bay City Capital LLC
Kim Helen Susan
Craig Adam R
Kolluri Krishna Kittu
Kerins Patrick J
Sandell Scott D
Drant Ryan D
Baskett Forest
Barris Peter J
Barrett M James
NEA 12 GP LLC
NEA Partners 12 Limited Partnership
Growth Equity Opportunities Fund LLC
New Enterprise Associates 12 Limited Partnership
DePinto Joseph I
Hurwitz Edward
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Sunesis Pharmaceuticals Inc VIRX
Restricted Stock Units · derivative
2024-11-25 Option exercise 9,034 $0.00
Sunesis Pharmaceuticals Inc VIRX
Common Stock
2024-11-25 Option exercise 25,219 $0.00
Sunesis Pharmaceuticals Inc VIRX
Restricted Stock Units · derivative
2024-11-25 Option exercise 25,219 $0.00
Sunesis Pharmaceuticals Inc VIRX
Common Stock
2024-11-25 Option exercise 9,034 $0.00
Sunesis Pharmaceuticals Inc VIRX
Restricted Stock Units · derivative
2024-08-25 Option exercise 9,034 $0.00
Sunesis Pharmaceuticals Inc VIRX
Common Stock
2024-08-25 Option exercise 25,219 $0.00
Sunesis Pharmaceuticals Inc VIRX
Common Stock
2024-08-25 Option exercise 9,034 $0.00
Sunesis Pharmaceuticals Inc VIRX
Restricted Stock Units · derivative
2024-08-25 Option exercise 25,219 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 18,750 $0.00
Sunesis Pharmaceuticals Inc VIRX
Stock Option (Right to Buy) · derivative
2024-06-20 Grant 50,000 $0.00
Sunesis Pharmaceuticals Inc VIRX
Restricted Stock Units · derivative
2024-05-25 Option exercise 9,035 $0.00
Sunesis Pharmaceuticals Inc VIRX
Restricted Stock Units · derivative
2024-05-25 Option exercise 25,219 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com